Massachusetts General Hospital: Kidney Failure, Chronic trials

The registry lists 15 Kidney Failure, Chronic studies with Massachusetts General Hospital as lead sponsor. 2 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 3Phase 2 2Phase 4 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Blood Volume Monitoring Via Critline in Volume Overload: Hospitalization and ReadmissionEnrolling by invitationNCT07866872
• Partners Calciphylaxis BiobankRecruitingNCT03032835
• Improving Care for Peritoneal Dialysis Patients With the CKD-PD AppCompletedNCT04797195Not applicableResults posted
• Helping Olfaction and Nutrition On Renal ReplacementCompletedNCT02479451Phase 2Results posted
• Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)CompletedNCT02314403Phase 1Results posted
• Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal DiseaseCompletedNCT02158052Not applicableResults posted
• Renal Allograft Tolerance Through Mixed ChimerismCompletedNCT01780454Phase 1/2Results posted
• DIVINE: Dialysis Infection and Vitamin D In New EnglandCompletedNCT00892099Not applicableResults posted
• Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis AccessWithdrawnNCT04614142Phase 4
• Kidney Information Network for Disease Research and EducationTerminatedNCT03321604
• Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney TransplantWithdrawnNCT03093740Phase 4
• Trial of Carbamylation in Renal Disease-Modulation With Amino Acid TherapyCompletedNCT02472834Not applicable
• Carbamylation in Renal Disease-modulation With Amino Acid TherapyCompletedNCT01612429Early Phase 1
• Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)CompletedNCT00854139Phase 1
• Accelerated Mortality on Renal ReplacementCompletedNCT00505180